Intracellular signalling in blood leucocytes shows multiple aberrations in acute pancreatitis (AP) complicated by organ dysfunction (OD). We studied whether the aberrations associate with severity of AP and occur in sepsis complicated by OD. The study comprises 14 sepsis patients (11 with shock), 18 AP patients (nine mild; six moderately severe; three severe) and 28 healthy volunteers. Within 48 h after admission to hospital, phosphorylation of nuclear factor-KB (NF-KB), signal transducers and activators of transcription (STATs) 1,3, and extracellular signal-regulated kinases 1/2 were measured from stimulated or nonstimulated leucocytes using phosphospecific whole blood flow cytometry. In sepsis, as compared with healthy subjects, phosphorylated NF-KB levels of monocytes promoted by bacterial lipopolysaccharides, tumour necrosis factor or Escherichia coli cells were lower (P < 0.001 for all), pSTAT1 levels of monocytes promoted by IL-6 were lower (P < 0.05 for all), and STAT3 was constitutively phosphorylated in monocytes, neutrophils and lymphocytes (P < 0.001 for all). In AP, severity was associated with proportions of pSTAT1-positive monocytes and lymphocytes promoted by IL-6 (P < 0.01 for both), constitutive STAT3 phosphorylation in neutrophils (P < 0.05), but not with any of the pNF-KB levels. Monocyte pSTAT3 fluorescence intensity, promoted by IL-6, was lower in sepsis and AP patients with OD than in AP patients without OD (P < 0.001). Collectively, signalling aberrations in sepsis with OD mimic those described previously in AP with OD. Possibility that aberrations in STAT1 and STAT3 pathways provide novel markers predicting evolution of OD warrants studies including patients presenting without OD but developing it during follow-up.
Introduction
Acute pancreatitis (AP) can either exhibit a mild, selflimiting course or develop into a severe systemic inflammation complicated by organ dysfunction (OD), the major cause of morbidity and mortality in AP [1, 2] . Regarding the systemic responses and the course of the development of OD, severe AP resembles septic shock [1, 3, 4] . Accordingly, the early proinflammatory stage may affect the evolution of OD in AP and sepsis, both characterized by acute and extremely severe systemic inflammation in terms of both clinical and laboratory findings. The proinflammatory reaction elicits an anti-inflammatory response, which may lead to excessive immunosuppression, increasing the risk of secondary infections and infectionassociated OD [1] .
To improve the outcome in severe AP and septic shock, the patient's immune status and subsequent immunomodulation strategy should be determined as early as possible after onset of the symptoms [5] [6] [7] . However, the current scoring systems, such as acute physiology and chronic health evaluation (APACHE) II [8] or acute phase reactants [7, 9, 10] , only exert a limited capacity to predict clinical outcome. Numerous biomarker candidates associated with acute inflammation induced by AP or infection have emerged [2, 6, 7, 9, [11] [12] [13] . We recently found that circulating levels of interleukin (IL)-8 and hepatocyte growth factor (HGF) measured on admission to hospital predict the risk of developing OD during hospitalization in patients with AP [14] . However, the generation of soluble mediators, such as pro-and anti-inflammatory cytokines, requires new protein synthesis and is therefore timeconsuming. It is preceded by inflammatory gene activation via leucocyte intracellular signalling pathways. Thus, activation of intracellular signalling in blood leucocytes would represent a very early stage of systemic inflammatory response. The major inflammation-associated signalling pathways include the transcription factors such as nuclear factor kappa B (NF-KB), signal transducers and activators of transcription (STATs), and the mitogen-activated protein (MAP) kinases. Although the activation of these pathways has been studied in experimental models of AP [15, 16] and sepsis [17] , data from AP and sepsis patients remain limited. Leucocyte signalling pathways have been studied in non-infectious, chronic disorders typified by the presence of systemic inflammation of varying intensities, such as alcoholic and non-alcoholic steatohepatitis [18, 19] , cardiovascular disorders [20] , and rheumatoid arthritis [21] [22] [23] [24] and autoinflammatory syndrome [25] , both associated with the development of amyloidosis.
To search for potential markers for predicting OD in patients with AP, we recently screened intracellular signalling profiles in circulating leucocytes and found a variety of aberrations in the activation of NF-KB, STAT1 and 3, and extracellular signal-regulated kinases (ERK)1/2, a MAP kinase, in AP patients who had OD and were treated at the intensive care unit (ICU) [26] [27] [28] . Obviously, the aberrations observed have potential for predicting OD providing that they (1) can also occur in patients with mild AP, indicating that they are not promoted by OD itself, and (2) associate with the severity of AP, that is can distinguish at early stage of AP the patients who will recover without OD from those who are bound to develop OD. Taking into account the similarities in OD between sepsis and AP [1, 3, 4] , we reasoned that if leucocyte signalling aberrations in AP, a non-infectious disorder at the early stage of the disease [29] , are similar to those in septic shock promoted by bacterial infection, the same signalling profile might predict the outcome of both AP and sepsis. Therefore, in this study, we examined, using the same assay conditions, whether sepsis patients with OD show leucocyte signalling aberrations which mimic those described previously in AP patients with OD [26] [27] [28] . Secondly, using the same study protocol, we examined which of the aberrations in AP patients associate with the severity of AP. The results show that signalling aberrations in sepsis with OD are close to those observed previously in AP with OD, and in AP patients, particularly STAT1 and three pathways reveal aberrations associated with disease severity.
Materials and methods
Patients and definitions. This prospective pilot study comprises 14 patients with sepsis enrolled at the intensive care unit and 18 patients with AP enrolled at the Emergency Department at Helsinki University Hospital between February 2010 and May 2012. Twenty-eight healthy volunteers (19 women and eight men, median age 35 years, range 24-68) were recruited from hospital and laboratory personnel. The Surgical Ethical Review Board of the Joint Authority for the Hospital District of Helsinki and Uusimaa approved the study. Written informed consent was obtained from each patient or his/her next of kin.
Sepsis patients (as defined previously [30] ) were recruited within 48 h after hospital admission and those with concomitant malignancy, known immunological deficiency, or in-hospital sepsis were excluded. According to the recent definitions [31] , three patients had sepsis, that is OD with an acute increase in Sequential Organ Failure Assessment (SOFA) score of ≥2 points, and 11 patients fulfilled the criteria of septic shock, that is need of vasopressor to maintain mean arterial pressure ≥65 mmHg, and serum lactate level >2 mmol/l and were categorized to OD group. AP diagnoses were based on acute onset of epigastric pain, plasma amylase level ≥3 times the upper reference limit and/or characteristic findings in computed tomography (CT) [32] . Exclusion criteria were the onset of symptoms more than 72 h before hospital admission and >2 previous AP attacks. The severity of AP was retrospectively assessed according to the revised Atlanta Classification [33] into mild (no local or systemic complications), moderately severe (exacerbation of chronic illness or transient OD resolving within 48 h and/or local complication in CT) and severe (persistent OD > 48 h). The presence of OD was assessed by the Modified Marshall Score (MMS) [34] . OD was present, if a patient received ≥2 points from either respiratory, renal or cardiovascular evaluation.
Blood sampling. A 4-ml venous blood sample, obtained within 48 h (occasionally 61 h) after admission to hospital, was collected into a Falcon polypropylene tube (Becton Dickinson, Lincoln Park, NJ, USA) supplemented with pyrogen-free citrate phosphate dextrose (Baxter Health Care Ltd, Norfolk, UK, 0.1 ml/ml blood) and kept at room temperature until stimulations within 3 h of sampling. Each patient sample was compared to a sample obtained from a healthy volunteer within 2 weeks.
Biological agents and leucocyte agonists. For surface marker staining, the following monoclonal antibodies were used: fluorescein isothiocyanate (FITC)-conjugated anti-CD14 (clone Μ/P9 IgG 2b ), phycoerythrin (PE)-conjugated anti-HLA-DR (clone L243, IgG 2a ) and its isotype control (mouse IgG 2a ). For intracellular phosphospecific labelling, we used AlexaFluor647-conjugated anti-pNF-KB p65 (pS529) (clone K10-895.12.50, IgG 2b ), anti-STAT1 (pY701) (clone 4a, IgG 2a ), anti-ERK1/2 (pT202/pY204) (clone 20A, IgG 1 ) and PE-conjugated anti-STAT3 (pY705) (clone 4/P-STAT3, IgG 2a ). The antibodies were from Becton-Dickinson Biosciences (San Jose, CA).
The recombinant cytokines such as tumour necrosis factor (TNF) and IL-6 were from R&D (Minneapolis, MN, USA). Phorbol-12-myristate-13-acetate (PMA), Ca 2+ -ionophore A 23187 and Escherichia coli (E. coli) O111:B4 lipopolysaccharide were from Sigma (St. Louis, MO, USA). Whole E. coli bacteria were obtained from the National Institute for Health and Welfare (Helsinki, Finland), grown in brain heart infusion medium, pelleted and washed twice. A diluted culture was made to quantify viable bacteria. The bacteria were pelleted, resuspended in glycerol-tryptone soya broth medium and stored at À70°C. The stimuli were diluted in PBS before use.
Ex vivo stimulation and immunolabelling. The stimulation strategy of the signalling pathways in monocytes, neutrophils and lymphocytes was as follows: NF-KB stimulation by E. coli and LPS in monocytes and neutrophils and by TNF in each of the three cell types: STAT1 and STAT3 by IL-6 in each cell type, and ERK1/2 by the combination of PMA and A 23187 in each cell type. Thus, the blood sample was divided into 100 ll aliquots in Falcon polystyrene tubes (Becton Dickinson). The tubes were supplemented either with TNF 10 ng/ml (final concentration), IL-6 100 ng/ml, PMA + A 23187 each 1 lg/ml for 5 min, or lipopolysaccharide (LPS) 100 ng/ml, or E. coli (50 cells/leucocyte) for 10 min at +37°C. Reference tubes were incubated without stimulus.
After incubations, leucocyte fixation, red cell lysis and leucocyte permeabilization were performed according to BD Phosflow Protocol III for Human Whole Blood (http:// www.bdbiosciences.com/pharmingen/products/display_pro duct.php?keyID=94#3). After permeabilization, the samples were washed with BD Pharmingen Stain Buffer and resuspended in 100 ll of the buffer. Aliquots of AlexaFluor647-and PE-labelled phosphospecific monoclonal antibodies and anti-CD3-PerCP were added. The samples were incubated for 20 min in the dark at room temperature, washed, resuspended in 300 ll of the buffer, stored in the dark on ice and run on the flow cytometer within 3 h.
Flow cytometry. Data acquisition and analysis were carried out by FACSCanto II flow cytometer with FACSDIVA software (BD Sciences, San Jose, CA, USA). The anti-CD14-FITC label was used for identifying monocytes ( Figure S1 ). Although CD14 fluorescence intensity levels were significantly lower in sepsis than in healthy controls ( Figure S2 ), which agrees with previous studies [35] , monocytes from sepsis patients, like monocytes from AP patients and healthy subjects, were reasonably well separated from other leucocytes ( Figure S1 ). Neutrophils and lymphocytes were delineated according to their lightscattering properties, and CD14-FITC-positive monocytes were excluded using electronic gates. AlexaFluor647 and PE histograms were developed from stimulated and nonstimulated monocytes, neutrophils and lymphocytes ( Figure S3 ).
Flow cytometric data on the intracellular targets were determined as (a) the median of relative fluorescence units (RFU) of all cells of a given leucocyte population, (b) the proportion (%) of positively fluorescing cells and (c) the average RFU of (b); (b) and (c) were measured using a threshold method described in [26] . In brief, an electronic gate covering the brightest fluorescing cells was set manually to include less than but as close as possible to 5% of the cells in the non-stimulated sample, and the same gate was used to determine the proportion of positively fluorescing cells in the respective stimulus-treated sample. When compared to healthy controls' samples, (a) shows if the target molecule phosphorylation of the patient's sample is aberrant. The aberration can be due to different sizes of the normally responding cellular subpopulation [26] , shown by (b), or different capabilities of the responding cells to raise the target phosphorylation, shown by (c). In the whole blood assay, leucocyte activation may be caused directly by the stimulus, indirectly by mediators, such as cytokines released by nearby cells responding to the stimulus, or both [36] . The coefficient of variation was 5% within experiments and 10% between experiments. Consequently, if the average proportion of positively fluorescing cells of healthy control subjects (n = 28) was <10% in the stimulated samples, the cells were considered to be incapable of responding to the stimulus in the assay conditions used and the data were excluded. The omitted data include neutrophil STAT1 activated by IL-6 and neutrophil NF-KB activated by E. coli or LPS. Among the data excluded, the average proportion of positively fluorescing cells of AP and sepsis patients was also <10% or close to it, excluding the possibility that unlike the healthy subjects, the patients' cells would have been reactive. STAT3 was commonly phosphorylated constitutively, that is without ex vivo stimulation, in AP patients [27, 28] . The proportion of constitutively STAT3-phosphorylated cells (pSTAT3+ %) and their median RFU were determined as described [21, 27] . In brief, a marker was set on each cell population histogram of the healthy subject's sample so that it encompassed less than but as close as possible to 5% of the brightest events, and the markers were then copied to the respective patient's sample histograms ( Figure S4 ).
The proportions of the cells responding to a given stimulus and fluorescence intensities of them are presented in Table 2 , and the respective fluorescence intensities of all cells are given in Table S1 .
The proportion of human leucocyte antigen-antigen-D related (HLA-DR)-positive monocytes was determined as described previously [37] .
Plasma IL-8 and HGF levels. The plasma levels of IL-8 and HGF were measured using enzyme-linked immunosorbent assay. The reagents were from BD Biosciences, Erembodegem, Belgium (for IL-8), and R&D Systems Europe Ltd, Abingdon, UK (for HGF). The detection limits and interassay coefficients of variation were 0.8 pg/ml and 1.4% for IL-8, respectively, and 7.8 pg/ml and 7.1% for HGF, respectively.
Data analysis. The results are shown as median (quartiles or range). Mann-Whitney U-test was used to compare patients and healthy subjects, and patients with and without OD. Jonckheere-Terpstra trend test was used to find whether the signalling markers associate with AP severity. P values ≤0.05 were considered statistically significant, and two-tailed tests were used. Statistical analyses were executed with SPSS 22 software (IBM, Chicago, IL, USA).
Results

Patients
Patient characteristics are shown in Table 1 . The aetiology of sepsis was pneumonia (n = 7), cervical abscess (n = 1) or intra-abdominal infection (n = 5). In AP, the aetiology was alcohol (n = 11), biliary (n = 5) or idiopathic (n = 2). Upon hospital admission, 1/18 AP patients met the criteria of OD (Fig. 1A) , whereas at blood sampling, six patients had OD (Fig. 1B) . Of the latter, OD was transient (≤48 h) in three patients.
Signalling profiles in sepsis and acute pancreatitis
NF-KB
The degree of NF-KB phosphorylation was determined in response to TNF, LPS or whole E. coli bacteria ( Table 2) . In response to TNF, the proportion of the positively fluorescing cells (pNF-KB+ %) among monocytes and lymphocytes, and their fluorescence intensities were consistently lower in sepsis and in AP than in healthy subjects (P values < 0.001). In response to LPS or E. coli, pNF-KB+ % of monocytes and the respective fluorescence intensities were lower in sepsis and in AP (P values < 0.001). None of the differences associated with the severity of AP (Table 2) .
STAT1
In response to IL-6, pSTAT1+ % was lower in sepsis and in AP than in healthy subjects among monocytes and lymphocytes (P values < 0.001, Table 2 ) and associated with the severity of AP (P = 0.002 and 0.003, respectively. The respective pSTAT1 fluorescence intensity was lower among monocytes in sepsis (P = 0.030) and among monocytes and lymphocytes in AP (P < 0.05) and did not associate with the severity of AP (both P > 0.05).
Constitutive STAT3 phosphorylation
In non-stimulated samples, the pSTAT3 RFU values of monocytes, neutrophils and lymphocytes were significantly higher in sepsis and in AP than in healthy subjects (P values < 0.001, Table S2 ), indicating that the cells were constitutively activated in sepsis and in AP. Accordingly, pSTAT3+ % was higher in sepsis and in AP among monocytes, neutrophils and lymphocytes (P values < 0.001, Table 2 ). pSTAT3+ % of neutrophils associated with the severity of AP (P = 0.024).
IL-6-induced STAT3 phosphorylation
After exposure to IL-6, pSTAT3+ % of monocytes was lower in sepsis and in AP (P < 0.001 and P = 0.006, respectively). pSTAT3% of neutrophils was higher in sepsis and in AP (P < 0.001 for both) and that of lymphocytes was higher in sepsis (P = 0.043, Table 2 ) compared to healthy subjects. In sepsis and in AP, pSTAT3 fluorescence intensities of pSTAT3+ cells were lower among monocytes (P < 0.001 and P = 0.004, respectively) and higher among neutrophils (P = 0.038 and P < 0.001, respectively) compared to healthy subjects. pSTAT3 fluorescence intensity of neutrophils associated with the severity of AP (P = 0.05, Table 2 ).
ERK1/2
In response to PMA and Ca 2+ -ionophore A 23187 , the fluorescence intensity of pERK1/2+-monocytes was lower in sepsis and in AP (P = 0.001 and P = 0.003, respectively) and pERK1/2+ % of lymphocytes and their respective fluorescence intensity was lower in AP (P = 0.009 and P = 0.045, respectively) compared to healthy subjects. These differences did not associate with the severity of AP (Table 2 ). pERK1/2+ % of neutrophils was higher in sepsis compared to healthy subjects (P = 0.005, Table 2 ).
The differences in fluorescence intensities of the cells responding to the stimulus (Table 2) were similar to those of all cells between sepsis and healthy subjects, and between AP and healthy subjects (Table S1 ). Also, the relation of this fluorescence intensity to the severity of AP (Table 2) was very similar to those obtained by all cells (Table S1 ).
Patients with versus without OD
We reasoned that if a signalling marker (1) associates with AP severity and differs significantly from healthy subjects in (2) AP and (3) sepsis (Table 2) , it might discriminate the combined OD group from patients without OD. A total of six markers met the three criteria (Table 3) . Among these, pSTAT3 RFU of monocytes, after exposure to IL-6, was revealed to be lower in the OD group (P < 0.001), and the plasma levels of IL-8 and HGF higher (P values 0.002 and <0.001, respectively, Table 3 ).
Discussion
In this prospective pilot study, we found, first, that aberrations in blood leucocytes in sepsis patients with OD resemble those of AP patients with OD [26] [27] [28] . Second, aberrations in STAT1, STAT3 and ERK1/2 pathways associate with the severity of AP and might therefore be of prognostic value.
NF-KB plays a central role in the pathogenesis of inflammation [38] . Using electrophoretic mobility shift assay of blood mononuclear cells, NF-KB has been shown to be activated in sepsis [39] [40] [41] and in AP [42] [43] [44] , and NF-KB responses to LPS to be reduced in severe but not in mild AP [42] . Using whole blood flow cytometry, we found that after stimulation, NF-KB was phosphorylated in a lower proportion of monocytes, neutrophils and lymphocytes and at a lower level in the samples of sepsis and AP patients than in those of healthy subjects. The findings are in agreement with our previous results concerning AP patients with OD [26] [27] [28] and extend to show that depressed NF-KB phosphorylation did not associate with the severity of AP. Thus, while reduced NF-KB phosphorylation upon stimulation is a sensitive marker of systemic inflammation, it may not, at least on its own, serve as a useful prognostic factor. We also found that the proportions of pSTAT1-positive monocytes and lymphocytes, after IL-6 stimulation, were reduced in sepsis, similar to our previous results concerning AP patients with OD [26, 27] . Additionally, in the present study we showed that the proportions correlated inversely with the severity of AP. Our finding accords with the studies indicating that STAT1 phosphorylation induced by IL-6, the T helper 1-type cytokine interferon-gamma, is suppressed in activated T cells [45, 46] and that there is a shift from T helper 1-type response to T helper 2-type response in both sepsis [47, 48] and AP [49] [50] [51] . Obviously, STAT1 phosphorylation may provide a useful prognostic marker in AP.
Constitutive STAT3 phosphorylation occurs in sepsis [52] and AP [27, 28] . Here, we report that it is present in monocytes, neutrophils and lymphocytes in both sepsis and AP and that the proportion of pSTAT3-positive neutrophils correlates positively with the severity of AP. The role of activated STAT3 in inflammation is complex. It activates numerous genes, for example over 3000 genes in T cells [53] . As the targets of pSTAT3 include genes required for cell survival, proliferation and migration [53] [54] [55] , pSTAT3 may promote target organ inflammation [56, 57] . The cause of the constitutive STAT3 phosphorylation may involve increased circulating levels of STAT3-activating cytokines, for example IL-6 [21, 58] . Altogether, constitutive STAT3 phosphorylation provides an intriguing prognostic marker in AP.
Following IL-6 stimulation, the proportion of pSTAT3-positive monocytes and their phosphorylation levels were lower in sepsis or AP than in healthy subjects, and the levels correlated inversely with the severity of AP. In contrast, the respective proportions and phosphorylation levels of neutrophils were higher in sepsis or AP than in healthy subjects, and the levels correlated positively with AP severity. It is possible that along with the worsening of systemic inflammation, anti-inflammatory or immunosuppressive mechanisms become more prominent in circulating monocytes, thereby favouring depression of IL-6-induced STAT3 phosphorylation. The enhanced STAT3 response in neutrophils can be explained by STAT3 activation-related priming, which has been described in septic patients [52] .
After stimulation, phosphorylation levels of pERK1/2-positive monocytes in sepsis patients were lower than those in healthy subjects. Previously, we found a similar decrease in AP patients with OD [26] , and in the present study in AP patients in general, but the levels did not associate with the severity of AP.
The leucocyte signalling profile determinations in this study have limitations. Firstly, cell viability was not monitored. Cell damage may increase non-specific binding of antibodies to the cell membrane [59] . We have previously found that in blood sample obtained from a healthy subject, anticoagulated with citrate and incubated for 1 h at 37°C, about 90% of leucocytes remained viable, as determined by propidium iodide staining [60] . In addition, after stimulation with FMLP, a phagocyte agonist, the proportion of viable cells did not decrease. In fact, stimulation of neutrophils with FMLP, cells of Yersinia enterocolitica, or PMA increased neutrophil resistance to red cell lysing media-induced cellular injury determined by propidium iodide [61] . Such functional changes may have their origins from molecular control for activation and priming of phagocytes [62, 63] . The findings above give credence to the view that susceptibility to membrane injury and cell viability differs between blood leucocyte of AP or sepsis patients and healthy subjects. Indeed, the possibility that cell viability and different modes of cell death, including apoptosis [64] and
No OD (MMS < 2), n = 17
Mild AP, n = 9
Moderately severe AP, n = 6
Severe AP, n = 2 OD (MMS ≥ 2), n = 1 Severe AP, n = 1
Hospital admission
No OD (MMS < 2), n = 12
Moderately severe AP, n = 3* OD (MMS ≥ 2), n = 6
Moderately severe AP, n = 3
Severe AP, n = 3
At blood sampling Disease outcome B Figure 1 Flowchart of the patients with acute pancreatitis (AP) (A) on hospital admission and (B) at blood sampling (median 24 h after hospital entry; interquartile range, 15-41 h). The presence of organ dysfunction (OD) was determined according to the Modified Marshall score (MMS) [34] ) and the outcome of AP according to the revised Atlanta Classification [33] . *One patient had local complication in computed tomography but did not develop OD during treatment, whereas two patients developed transient OD after sampling.
Ó 2017 The Foundation for the Scandinavian Journal of Immunology necroptosis [65] , associate with severity of AP and sepsis warrants systematic studies. Secondly, we focused in this study on neutrophils, lymphocytes and monocytes and did not determine functional subpopulations of them, such as the proportion of non-classical monocytes characterized by low expression of CD14 and CD16 molecules on plasma membrane [35] . Thirdly, as in previous studies [26] [27] [28] , anti-CD14 mAb was added to and incubated in aliquots of blood samples concomitantly with the stimulus. However, in samples from healthy subjects, which served as biological comparison controls [66] , we observed no evidence for phosphorylation promoted by anti-CD14 mAb.
Whereas the immunopathogenic mechanisms of OD in AP and sepsis may differ from each other, there are also remarkable similarities [67, 68] . We therefore analysed whether any of the markers studied would distinguish the patients with OD from those without OD and found that IL-6-induced STAT3 phosphorylation levels in monocytes were significantly lower in the OD group. The patients were also separated up by circulating levels of IL-8 and HGF, which may identify on admission to hospital the patients in the highest risk to develop OD [14] . These data suggest that similar inflammatory processes contribute to the development of OD despite different triggering mechanisms [3, 68] . It is of note, however, that in addition to sepsis patients, the three AP patients with OD already had OD at the time of blood sampling (Fig. 1B) . Consequently, the present data permit no definitive conclusions on the ability of the markers to predict the development of OD.
Conclusions
The results show that (1) phosphorylation of NF-KB, STAT1, STAT3 and ERK1/2 in peripheral blood leucocytes of sepsis patients largely resembles those of AP patients and (2) phosphorylation of STAT1 and STAT3, but not NF-KB, associates with the severity of AP. Whether the markers aid in predicting OD needs to be studied prospectively in patients who do not have signs of OD at presentation but are bound to develop OD during hospitalization.
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